At the recent ASCO (American Society of Clinical Oncology) conference, announcements were made about the drug ABRAXANE (Nab-Paclitaxel) and its use in metastatic pancreatic cancer. Results of clinical trials showed some promising benefit from the drug, when combined with gemcitabine.
You can read more about this here:
http://www.pancreaticcancer.org.uk/abou ... two-months
We look forward to hearing more about this, and in particular, its licencing for use in the UK.
This forum contains news that Pancreatic Cancer UK and forum users have shared over the years.
1 post • Page 1 of 1